6.10
+0.30
+(5.17%)
At close: 8:00:58 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
36,555
36,555
8,780
12,405
--
Operating Expense
137,927
137,927
123,553
116,761
86,065
Operating Income
-101,372
-101,372
-114,773
-104,356
-86,065
Net Non Operating Interest Income Expense
12,638
12,638
9,908
3,122
120
Other Income Expense
-247
-247
166
167
140
Pretax Income
-88,981
-88,981
-104,699
-101,067
-85,805
Net Income Common Stockholders
-88,981
-88,981
-104,699
-101,067
-85,805
Diluted NI Available to Com Stockholders
-88,981
-88,981
-104,699
-101,067
-85,805
Basic EPS
-2.08
-1.65
-2.38
-2.60
-2.34
Diluted EPS
-2.08
-1.65
-2.38
-2.60
-2.34
Basic Average Shares
50,985.63
54,008.88
43,994.86
38,897.44
36,739.27
Diluted Average Shares
50,985.63
54,008.88
43,994.86
38,897.44
36,739.27
Total Operating Income as Reported
-101,372
-101,372
-114,773
-104,356
-86,065
Total Expenses
137,927
137,927
123,553
116,761
86,065
Net Income from Continuing & Discontinued Operation
-88,981
-88,981
-104,699
-101,067
-85,805
Normalized Income
-88,981
-88,981
-104,699
-101,067
-85,805
Interest Income
--
--
--
--
120
Net Interest Income
12,638
12,638
9,908
3,122
120
EBIT
-101,372
-101,372
-114,773
-104,356
-86,065
EBITDA
-99,195
-99,195
-112,304
-102,810
-85,091
Reconciled Depreciation
2,177
2,177
2,469
1,546
974
Net Income from Continuing Operation Net Minority Interest
-88,981
-88,981
-104,699
-101,067
-85,805
Normalized EBITDA
-99,195
-99,195
-112,304
-102,810
-85,091
12/31/2021 - 7/15/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DNTH Dianthus Therapeutics, Inc.
18.71
+6.25%
PHVS Pharvaris N.V.
12.62
+5.17%
TRML Tourmaline Bio, Inc.
14.09
+7.56%
COGT Cogent Biosciences, Inc.
4.5800
+7.51%
IDYA IDEAYA Biosciences, Inc.
17.11
+2.15%
TIL Instil Bio, Inc.
16.80
+11.78%
BCYC Bicycle Therapeutics plc
7.07
+5.52%
LTRN Lantern Pharma Inc.
3.5300
+9.97%
ALXO ALX Oncology Holdings Inc.
0.5013
+2.31%
NKTX Nkarta, Inc.
1.7000
+7.94%